Company intelligence / Profile preview

Swan Neck Bio

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

Swan Neck Bio is a spin-out from White Labs focused on providing scalable, single-use bioreactor solutions to help precision fermentation and biomass companies trial, validate, and scale their microorganisms from lab to pilot production. Their FlexCell technology enables cost-effective scaling up to 1,000L volumes. They partner with foodtech/biotech startups to accelerate time-to-market by derisking the process of moving from lab-scale experiments to commercial production.

Modalities: Microbial fermentationPrecision fermentation
Industry: Non-Drug Biotech

Partnerships

Gourmey (client/collaborator)Kost (client/collaborator)

Beyond the preview

Go deeper on Swan Neck Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Swan Neck Bio.

Explore the full profile